Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest acetanilides Stories

212020c01ec1e4b60116e8bc11c9c26e1
2010-11-08 14:05:00

Experts have warned that prolonged use of paracetamol and painkillers during pregnancy may cause health risk to baby boys. Research suggests that drugs increase the risk of undescended testicles in male babies, which is a condition linked to infertility and cancer later in life. Doctors already advise pregnant women to avoid taking these drugs if possible to help protect the unborn child. Experts say the study warranted further research "as a matter of priority." However, it should not be...

2010-01-20 10:32:00

NASHVILLE, Tenn., Jan. 20 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) has donated 15,000 vials of Caldolor® (ibuprofen) Injection, an intravenous form of ibuprofen, to Haitian relief effort. Caldolor is the first and only injectable product approved for the treatment of pain and reduction of fever in the United States. As health conditions in Haiti continue to deteriorate, Caldolor is expected to help those suffering from fever as a result...

2009-12-09 08:00:00

Nashville, Tenn., Dec. 9 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that it has entered into an exclusive agreement with DB Pharm Korea Co. Ltd., a Korean-based pharmaceutical company, for the commercialization of Caldolor® (ibuprofen) Injection in South Korea. Designed to treat pain and fever in the hospital setting, Caldolor was approved by the U.S. Food and Drug Administration and launched by Cumberland in the United States...

2009-10-05 06:30:00

NASHVILLE, Tenn., Oct. 5 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009. Data from the following clinical trials of Caldolor will be...

2009-09-30 07:00:00

SAN DIEGO, Sept. 30 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that it will host a live webcast of its Analyst Day on Wednesday, October 7, 2009 at 11:30 a.m. Eastern Time. Cadence's senior management team, led by Ted Schroeder, President and Chief Executive Officer, will provide an...

879e08983562a9c187285ba3b4ae03d81
2009-07-15 09:25:00

Scientists in Louisiana are reporting development of a process for producing large batches of a new and potentially safer form of acetaminophen, the widely used pain-reliever now the source of growing concern over its potentially toxic effects on the liver. Their study, which could speed development of a next-generation pain-reliever, is scheduled for the July 17 issue of ACS' Organic Process Research & Development, a bi-monthly journal.In June, an advisory panel of the U. S. Food and...

2009-05-05 09:21:12

A new UNC study published online in the journal Genome Research describes a new, more effective and less costly method for testing drugs for potential toxicity and one that could also result in more people benefiting from existing drugs. Adverse reactions to drugs represent one of the leading causes of death in the United States. But there may be a way to predict who is most likely to suffer a toxic side effect to a drug before they have even taken it. A study published online in the journal...

2009-04-27 07:30:00

SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced today that data from clinical trials of its investigational product candidate, Acetavance(TM) (intravenous acetaminophen), will be presented at the American Society of Regional Anesthesia and Pain Medicine (ASRA) 34th Annual Regional Anesthesia Meeting in Phoenix, Arizona on April 30, 2009 and at the Society of Hospital Medicine (SHM) Annual Meeting in Chicago, Illinois on May 16, 2009. At...

4fe3317b8d0389943d7670bd3f08a91a1
2009-01-27 14:00:00

New research suggests a dose of aspirin may be able to prevent liver damage caused by paracetamol or heavy drinking. Researchers from Yale University found that aspirin cut death rates in mice given a paracetamol overdose. It is likely that aspirin interferes with a chemical pathway that triggers damaging inflammation within the liver, but the British Liver Trust said it was not yet proven to help humans. In the UK, liver cirrhosis rates have risen in recent years as people drink more...

2008-12-29 22:09:52

The pain reliever acetaminophen is not free of gastrointestinal side effects at high doses, researchers in Turkey found. Dr. Alis Soylu and colleagues Dr. Sadi Konuk and Dr. Lutfi Kirdar at Kartal Research and Training Hospitals in Istanbul, Turkey, studied 50 patients admitted to the emergency department with high dose analgesic -- acetaminophen -- ingestion with suicidal intent. Thirty patients with or without mild complaints of dyspepsia -- indigestion -- were selected as the control...